345 related articles for article (PubMed ID: 26195756)
1. Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations.
Rozhok AI; DeGregori J
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):8914-21. PubMed ID: 26195756
[TBL] [Abstract][Full Text] [Related]
2. Stochastic modeling indicates that aging and somatic evolution in the hematopoetic system are driven by non-cell-autonomous processes.
Rozhok AI; Salstrom JL; DeGregori J
Aging (Albany NY); 2014 Dec; 6(12):1033-48. PubMed ID: 25564763
[TBL] [Abstract][Full Text] [Related]
3. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
4. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
5. Determining cancer risk: the evolutionary multistage model or total stem cell divisions?
Nunney L; Thai K
Proc Biol Sci; 2020 Dec; 287(1941):20202291. PubMed ID: 33323077
[TBL] [Abstract][Full Text] [Related]
6. Peto's paradox and the hallmarks of cancer: constructing an evolutionary framework for understanding the incidence of cancer.
Nunney L; Muir B
Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056359
[TBL] [Abstract][Full Text] [Related]
7. A generalized theory of age-dependent carcinogenesis.
Rozhok A; DeGregori J
Elife; 2019 Apr; 8():. PubMed ID: 31034356
[TBL] [Abstract][Full Text] [Related]
8. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations.
Marusyk A; DeGregori J
Biochim Biophys Acta; 2008 Jan; 1785(1):1-11. PubMed ID: 17980163
[TBL] [Abstract][Full Text] [Related]
9. Population risk and physiological rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States.
Herrero-Jimenez P; Tomita-Mitchell A; Furth EE; Morgenthaler S; Thilly WG
Mutat Res; 2000 Jan; 447(1):73-116. PubMed ID: 10686307
[TBL] [Abstract][Full Text] [Related]
10. Only three driver gene mutations are required for the development of lung and colorectal cancers.
Tomasetti C; Marchionni L; Nowak MA; Parmigiani G; Vogelstein B
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):118-23. PubMed ID: 25535351
[TBL] [Abstract][Full Text] [Related]
11. The hierarchical model of stem cell genesis explains the man mouse paradox, Peto's paradox, the red cell paradox and Wright's enigma.
Morris JA
Med Hypotheses; 2014 Dec; 83(6):713-7. PubMed ID: 25459141
[TBL] [Abstract][Full Text] [Related]
12. The evolution of lifespan and age-dependent cancer risk.
Rozhok AI; DeGregori J
Trends Cancer; 2016 Oct; 2(10):552-560. PubMed ID: 28439564
[TBL] [Abstract][Full Text] [Related]
13. The guardians of inherited oncogenic vulnerabilities.
Arnal A; Tissot T; Ujvari B; Nunney L; Solary E; Laplane L; Bonhomme F; Vittecoq M; Tasiemski A; Renaud F; Pujol P; Roche B; Thomas F
Evolution; 2016 Jan; 70(1):1-6. PubMed ID: 26519218
[TBL] [Abstract][Full Text] [Related]
14. Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?
DeGregori J
Oncogene; 2013 Apr; 32(15):1869-75. PubMed ID: 22751134
[TBL] [Abstract][Full Text] [Related]
15. Solutions to Peto's paradox revealed by mathematical modelling and cross-species cancer gene analysis.
Caulin AF; Graham TA; Wang LS; Maley CC
Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056366
[TBL] [Abstract][Full Text] [Related]
16. The evolutionary dynamics and fitness landscape of clonal hematopoiesis.
Watson CJ; Papula AL; Poon GYP; Wong WH; Young AL; Druley TE; Fisher DS; Blundell JR
Science; 2020 Mar; 367(6485):1449-1454. PubMed ID: 32217721
[TBL] [Abstract][Full Text] [Related]
17. The population genetics of multistage carcinogenesis.
Nunney L
Proc Biol Sci; 2003 Jun; 270(1520):1183-91. PubMed ID: 12816658
[TBL] [Abstract][Full Text] [Related]
18. Negative clonal selection in tumor evolution.
Beckman RA; Loeb LA
Genetics; 2005 Dec; 171(4):2123-31. PubMed ID: 16143627
[TBL] [Abstract][Full Text] [Related]
19. Can Peto's paradox be used as the null hypothesis to identify the role of evolution in natural resistance to cancer? A critical review.
Ducasse H; Ujvari B; Solary E; Vittecoq M; Arnal A; Bernex F; Pirot N; Misse D; Bonhomme F; Renaud F; Thomas F; Roche B
BMC Cancer; 2015 Oct; 15():792. PubMed ID: 26499116
[TBL] [Abstract][Full Text] [Related]
20. An evolutionary model of carcinogenesis.
Gatenby RA; Vincent TL
Cancer Res; 2003 Oct; 63(19):6212-20. PubMed ID: 14559806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
